Literature DB >> 9111565

Multicentricity and recurrence of breast cancer.

M Baum, J S Vaidya, I Mittra.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9111565     DOI: 10.1016/S0140-6736(05)60950-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Functional intercomparison of intraoperative radiotherapy equipment - Photon Radiosurgery System.

Authors:  Kris S Armoogum; John M Parry; Salam K Souliman; David G Sutton; Colin D Mackay
Journal:  Radiat Oncol       Date:  2007-02-27       Impact factor: 3.481

2.  Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems.

Authors:  Jayant Sharad Vaidya; Uma Jayant Vaidya; Michael Baum; Max Kishor Bulsara; David Joseph; Jeffrey S Tobias
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

3.  The Roles of the Learned Societies in Improving Quality of Life in the context of Globalisation.

Authors:  Michael Baum
Journal:  Ann Med Surg (Lond)       Date:  2012-08-10

4.  Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth?

Authors:  Michael Retsky; Romano Demicheli; William Hrushesky; Michael Baum; Isaac Gukas
Journal:  Cancers (Basel)       Date:  2010-03-30       Impact factor: 6.639

5.  Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.

Authors:  Jayant S Vaidya; Max Bulsara; Christobel Saunders; Henrik Flyger; Jeffrey S Tobias; Tammy Corica; Samuele Massarut; Frederik Wenz; Steffi Pigorsch; Michael Alvarado; Michael Douek; Wolfgang Eiermann; Chris Brew-Graves; Norman Williams; Ingrid Potyka; Nicholas Roberts; Marcelle Bernstein; Douglas Brown; Elena Sperk; Siobhan Laws; Marc Sütterlin; Steinar Lundgren; Dennis Holmes; Lorenzo Vinante; Fernando Bozza; Montserrat Pazos; Magali Le Blanc-Onfroy; Günther Gruber; Wojciech Polkowski; Konstantin J Dedes; Marcus Niewald; Jens Blohmer; David McCready; Richard Hoefer; Pond Kelemen; Gloria Petralia; Mary Falzon; Michael Baum; David Joseph
Journal:  JAMA Oncol       Date:  2020-07-09       Impact factor: 31.777

6.  Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.

Authors:  Jayant S Vaidya; Max Bulsara; Michael Baum; Frederik Wenz; Samuele Massarut; Steffi Pigorsch; Michael Alvarado; Michael Douek; Christobel Saunders; Henrik L Flyger; Wolfgang Eiermann; Chris Brew-Graves; Norman R Williams; Ingrid Potyka; Nicholas Roberts; Marcelle Bernstein; Douglas Brown; Elena Sperk; Siobhan Laws; Marc Sütterlin; Tammy Corica; Steinar Lundgren; Dennis Holmes; Lorenzo Vinante; Fernando Bozza; Montserrat Pazos; Magali Le Blanc-Onfroy; Günther Gruber; Wojciech Polkowski; Konstantin J Dedes; Marcus Niewald; Jens Blohmer; David McCready; Richard Hoefer; Pond Kelemen; Gloria Petralia; Mary Falzon; David J Joseph; Jeffrey S Tobias
Journal:  BMJ       Date:  2020-08-19

7.  New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.

Authors:  Jayant S Vaidya; Max Bulsara; Michael Baum; Frederik Wenz; Samuele Massarut; Steffi Pigorsch; Michael Alvarado; Michael Douek; Christobel Saunders; Henrik Flyger; Wolfgang Eiermann; Chris Brew-Graves; Norman R Williams; Ingrid Potyka; Nicholas Roberts; Marcelle Bernstein; Douglas Brown; Elena Sperk; Siobhan Laws; Marc Sütterlin; Tammy Corica; Steinar Lundgren; Dennis Holmes; Lorenzo Vinante; Fernando Bozza; Montserrat Pazos; Magali Le Blanc-Onfroy; Günther Gruber; Wojciech Polkowski; Konstantin J Dedes; Marcus Niewald; Jens Blohmer; David McReady; Richard Hoefer; Pond Kelemen; Gloria Petralia; Mary Falzon; David Joseph; Jeffrey S Tobias
Journal:  Br J Cancer       Date:  2021-05-25       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.